AI assistant
Sending…
Ilirija d.d. — Interim / Quarterly Report 2018
Apr 30, 2018
2092_10-q_2018-04-30_ddbd1bce-9fa8-484e-b306-4fab9d46f180.pdf
Interim / Quarterly Report
Open in viewerOpens in your device viewer
| Annex 1. Reporting period |
01.01. | do | 31.03.2018. | ||||
|---|---|---|---|---|---|---|---|
| Quarterly financial report TFI-POD | |||||||
| Tax number (MB): | 03311953 | ||||||
| Company registration number (MBS): |
060032302 | ||||||
| Personal identification number (OIB): |
05951496767 | ||||||
| Issuing company: ILIRIJA d.d. | |||||||
| Postal code and place | 23210 | BIOGRAD NA MORU | |||||
| Street and house number: TINA UJEVIĆA 7 | |||||||
| E-mail address: [email protected] | |||||||
| Internet address www.ilirijabiograd.com | |||||||
| unicipality/city code and name | 22 | BIOGRAD NA MORU | |||||
| County code and name | 13 | ZADARSKA | Number of employees: | 240 | |||
| Consolidated report: | NO | (period end) NKD code: |
5510 | ||||
| Companies of the consolidation subject (according to IFRS): | Seat: | MB: | |||||
| Bookkeeping service: | |||||||
| Contact person: | STRPIĆ ZORKA | ||||||
| Telephone: 023/383178 | (only surname and name) | Telefaks: | 023/384564 | ||||
| E-mail address: [email protected] | |||||||
| Family name and name: RAŽNJEVIĆ GORAN | |||||||
| (person authorized to represent the company) | |||||||
| Documents disclosed: and notes to financial statements); 2. Management Interim Report; |
3. Declaration of the persons responsible for preparing the issuer's statements; | 1. Financial statements (Balance Sheet, Income Statement, Cash Flow Statement, Statement of Changes in Equity | |||||
| L.S. | (signature of the person authorized to represent the company) |
Balance Sheet
as of 31/03/2018
| Company: ILIRIJA d.d. BIOGRAD NA MORU | |||
|---|---|---|---|
| Position | AOP | Previous | Current |
| period | period | ||
| 1 | 2 | 3 | 4 |
| A) RECEIVABELS FOR SUBSCRIBED NOT PAID CAPITAL | 001 | ||
| B) NON-CURRENT ASSETS (003+010+020+029+033) | 002 | 407.395.772 | 424.385.649 |
| I. INTANGIBLE ASSETS (004 to 009) | 003 | 336.452 | 299.528 |
| 1. Expenditure for development | 004 | ||
| 2. Concessions, patents, licenses, trademarks, service marks, software and other rights | 005 | ||
| 3. Goodwill | 006 | ||
| 4. Advances for purchase of intangible assets | 007 | ||
| 5. Intangible assets in progress | 008 | ||
| 6. Other intangible assets | 009 | 336.452 | 299.528 |
| II. PROPERTY, PLANT AND EQUIPMENT (011 to 019) | 010 | 407.019.320 | 424.047.427 |
| 1. Land | 011 | 42.340.227 | 43.295.283 |
| 2. Buildings | 012 | 232.347.442 | 241.132.567 |
| 3. Plant and equipement | 013 | 42.304.303 | 51.453.578 |
| 4. Tools, working inventory and transportation assets | 014 | ||
| 5. Biological assets | 015 | ||
| 6. Advances for purchase of tangible assets | 016 | 1.239.522 | 2.573.552 |
| 7. Tangible assets in progress | 9.110.601 | 7.128.906 | |
| 8. Other tangible assets | 017 | ||
| 018 | |||
| 9. Investment in real-estate | 019 | 79.677.225 | 78.463.541 |
| III. NON-CURRENT FINANCIAL ASSETS (021 to 028) | 020 | 40.000 | 38.694 |
| 1. Share in related parties | 021 | 40.000 | 38.694 |
| 2. Loans to related parties | 022 | ||
| 3. Participating interests (shares) | 023 | ||
| 4. Loans to companies with participating interest | 024 | ||
| 5. Investments in securities | 025 | ||
| 6. Loans, deposits, etc. | 026 | ||
| 7. Other non-current financial assets | 027 | ||
| 8. Equity-accounted investments | 028 | ||
| IV. RECEIVABLES (030 to 032) | 029 | 0 | 0 |
| 1. Receivables from related parties | 030 | ||
| 2. Receivables arising from sales on credit | 031 | ||
| 3. Other receivables | 032 | ||
| V. DEFERRED TAX ASSET | 033 | ||
| C) CURRENT ASSETS (035+043+050+058) | 034 | 12.412.507 | 12.011.819 |
| I. INVENTORIES (036 to 042) | 035 | 2.358.997 | 2.213.961 |
| 1. Raw materials and supplies | 036 | 2.358.997 | 2.213.961 |
| 2. Production in progress | 037 | ||
| 3. Finished products | 038 | ||
| 4. Merchandise | 039 | ||
| 5. Advances for inventories | 040 | ||
| 6. Long term assets held for sale | |||
| 7. Biological assets | 041 | ||
| II. RECEIVABLES (044 to 049) | 042 | 6.543.758 | 7.860.784 |
| 1. Receivables from related parties | 043 | ||
| 2. Receivables from end-customers | 044 | ||
| 045 | 5.292.150 | 6.579.632 | |
| 3. Receivables from participating parties | 046 | ||
| 4. Receivables from employees and members of the company | 047 | 826.678 | 837.469 |
| 5. Receivables from government and other institutions | 048 | 330.912 | 379.374 |
| 6. Other receivables | 049 | 94.018 | 64.309 |
| III. CURRENT FINANCIAL ASSETS (051 to 057) | 050 | 2.434.811 | 1.717.081 |
| 1. Share in related parties | 051 | ||
| 2. Loans to related parties | 052 | ||
| 3. Participating interests (shares) | 053 | ||
| 4. Loans to companies with participating interest | 054 | ||
| 5. Investments in securities | 055 | ||
| 6. Loans, deposits, etc. | 056 | 2.434.811 | 2.055.765 |
| 7. Other financial assets | 057 | ||
| IV. CASH AND CASH EQUIVALENTS | 058 | 1.074.941 | 219.993 |
| D) PREPAYMENTS AND ACCRUED INCOME | 059 | ||
| E) TOTAL ASSETS (001+002+034+059) | 060 | 419.808.279 | 436.397.468 |
| F) OFF BALANCE SHEET ITEMS | 061 |
| EQUITY AND LIABILITIES | |||
|---|---|---|---|
| A) ISSUED CAPITAL AND RESERVES (063+064+065+071+072+075+078) | 062 | 278.359.544 | 299.275.231 |
| I. SUBSCRIBED SHARE CAPITAL | 063 | 174.977.880 | 229.146.480 |
| II. CAPITAL RESERVES | 064 | 26.723.874 | 2.723.874 |
| III.RESERVES FROM PROFIT (066+067-068+069+070) | 065 | 23.435.964 | 22.758.389 |
| 1. Legal reserves | 066 | 9.477.986 | 9.477.986 |
| 2. Reserve for own shares | 067 | 6.975.716 | 6.975.716 |
| 3. Treasury shares and shares (deductible items) | 068 | 540.417 | 1.217.992 |
| 4. Statutory reserves | 069 | ||
| 5. Other reserves | 070 | 7.522.679 | 7.522.679 |
| IV. REVALUATION RESERVES | 071 | ||
| V. RETAINED EARNINGS OR LOSS CARRIED FORWARD (073-074) | 072 | 50.546.190 | 41.326.486 |
| 1. Retained earnings | 073 | 50.546.190 | 41.326.486 |
| 2. Loss carried forward | 074 | ||
| VI. NET PROFIT OR LOSS FOR THE PERIOD (076-077) | 075 | 2.675.636 | 3.320.002 |
| 1. Net profit for the period | 076 | 2.675.636 | 3.320.002 |
| 2. Net loss for the period | 077 | ||
| VII. MINORITY INTEREST | 078 | ||
| B) PROVISIONS (080 to 082) | 079 | 0 | 0 |
| 1. Provisions for pensions, severance pay and similar liabilities | 080 | ||
| 2. Provisions for tax liabilities | 081 | ||
| 3. Other provisions | 082 | ||
| C) NON-CURRENT LIABILITIES (084 to 092) | 083 | 109.846.075 | 110.288.785 |
| 1. Liabilites to related parties | 084 | ||
| 2. Liabilities for loans, deposits, etc. | 085 | ||
| 3. Liabilities to banks and other financial institutions | 086 | 109.846.075 | 110.288.785 |
| 4. Liabilities for advances | 087 | ||
| 5. Trade payables | 088 | ||
| 6. Commitments on securities | 089 | ||
| 7. Liabilities to companies with participating interest | 090 | ||
| 8. Other non-current liabilities | 091 | ||
| 9. Deferred tax liabilities | 092 | ||
| D) CURRENT LIABILITIES (094 to 105) | 093 | 26.132.786 | 22.398.973 |
| 1. Liabilites to related parties | 094 | ||
| 2. Liabilities for loans, deposits, etc. | 095 | ||
| 3. Liabilities to banks and other financial institutions | 096 | 11.982.449 | 8.035.244 |
| 4. Liabilities for advances | 097 | ||
| 5. Trade payables | 098 | 9.038.461 | 7.922.632 |
| 6. Commitments on securities | 099 | 1.500.000 | |
| 7. Liabilities to companies with participating interest | 100 | ||
| 8. Liabilities to emloyees | 101 | 1.256.163 | 1.379.031 |
| 9. Taxes, contributions and similar liabilities | 102 | 1.361.294 | 3.750.775 |
| 10. Liabilities arising from share in the result | 103 | ||
| 11. Liabilities arising from non-current assets held for sale | 104 | ||
| 12. Other current liabilities | 105 | 994.419 | 1.311.291 |
| E) ACCRUED EXPENSES AND DEFERRED INCOME | 106 | 5.469.874 | 4.434.479 |
| F) TOTAL EQUITY AND LIABILITIES (062+079+083+093+106) | 107 | 419.808.279 | 436.397.468 |
| G) OFF BALANCE SHEET ITEMS | 108 | ||
| ADDITION TO BALANCE SHEET (only for consolidated financial statements) | |||
| ISSUED CAPITAL AND RESERVES | |||
| 1. Attributable to majority owners | 109 | ||
| 2. Attributable to minority interest | 110 |
Income statement period 01/01/2018 to 31/03/2018
Company: ILIRIJA d.d. BIOGRAD NA MORU
| Position | AOP | Previous period | Current period | |||
|---|---|---|---|---|---|---|
| Cummulative | Quarter | Cummulative | Quarter | |||
| 1 | 2 | 3 | 4 | 5 | 6 | |
| I. OPERATING INCOME (112 to 113) | 111 | 20.642.373 | 20.642.373 | 23.749.772 | 23.749.772 | |
| 1. Sales revenues | 112 | 20.565.717 | 20.565.717 | 23.448.076 | 23.448.076 | |
| 2. Other operating revenues | 113 | 76.656 | 76.656 | 301.696 | 301.696 | |
| II. OPERATING COSTS (115+116+120+124+125+126+129+130) | 114 | 16.869.128 | 16.869.128 | 19.350.018 | 19.350.018 | |
| 1. Change in inventories of work in progress | 115 | |||||
| 2. Material expenses (117 to 119) | 116 | 5.156.741 | 5.156.741 | 5.360.683 | 5.360.683 | |
| a) Costs of raw materials | 117 | 2.072.545 | 2.072.545 | 2.498.181 | 2.498.181 | |
| b) Cost of goods sold | 118 | |||||
| c) Other material expenses | 119 | 3.084.196 | 3.084.196 | 2.862.502 | 2.862.502 | |
| 3. Employee benefits expenses (121 to 123) | 120 | 6.131.313 | 6.131.313 | 6.821.463 | 6.821.463 | |
| a) Net salaries | 121 | 3.689.787 | 3.689.787 | 4.068.966 | 4.068.966 | |
| b) Tax and contributions from salary expenses | 122 | 1.541.701 | 1.541.701 | 1.751.395 | 1.751.395 | |
| c) Contributions on salary | 123 | 899.825 | 899.825 | 1.001.102 | 1.001.102 | |
| 4. Depreciation and amortisation | 124 | 2.551.212 | 2.551.212 | 2.788.869 | 2.788.869 | |
| 5. Other expenses | 125 | 2.911.900 | 2.911.900 | 3.394.306 | 3.394.306 | |
| 6. Write down of assets (127+128) | 126 | 0 | 0 | 0 | 0 | |
| a) non-current assets (except financial assets) | 127 | |||||
| b) current assets (except financial assets) | 128 | |||||
| 7. Provisions | 129 | |||||
| 8. Other operating costs | 130 | 117.962 | 117.962 | 984.697 | 984.697 | |
| III. FINANCIAL INCOME (132 to 136) | 131 | 23.419 | 23.419 | 22.186 | 22.186 | |
| 1. Interest, foreign exchange differences, dividens and similar income from related parties | 132 | 23.419 | 23.419 | 22.186 | 22.186 | |
| 2. Interest, foreign exchange differences, dividens and similar income from third parties | 133 | |||||
| 3. Income from investments in associates and joint ventures | 134 | |||||
| 4. Unrealised gains (income) from financial assets | 135 | |||||
| 5. Other financial income | 136 | |||||
| IV. FINANCIAL EXPENSES (138 to 141) | 137 | 1.121.028 | 1.121.028 | 1.101.938 | 1.101.938 | |
| 1. Interest, foreign exchange differences, dividends and similar income from related parties | 138 | |||||
| 2. Interest, foreign exchange differences, dividends and similar income from third parties | 139 | 1.121.028 | 1.121.028 | 1.101.938 | 1.101.938 | |
| 3. Unrealised losses (expenses) from financial assets | 140 | |||||
| 4. Other financial expenses | 141 | |||||
| V. SHARE OF PROFIT FROM ASSOCIATED COMPANIES | 142 | |||||
| VI. SHARE OF LOSS FROM ASSOCIATED COMPANIES | 143 | |||||
| VII. EXTRAORDINARY - OTHER INCOME | 144 | |||||
| VIII. EXTRAORDINARY - OTHER EXPENSES | 145 | |||||
| IX. TOTAL INCOME (111+131+142+144) | 146 | 20.665.792 | 20.665.792 | 23.771.958 | 23.771.958 | |
| X. TOTAL EXPENSES (114+137+143+145) | 147 | 17.990.156 | 17.990.156 | 20.451.956 | 20.451.956 | |
| XI. PROFIT OR LOSS BEFORE TAXES (146-147) | 148 | 2.675.636 | 2.675.636 | 3.320.002 | 3.320.002 | |
| 1. Profit before taxes (146-147) | 149 | 2.675.636 | 2.675.636 | 3.320.002 | 3.320.002 | |
| 2. Loss before taxes (147-146) | 150 | 0 | 0 | 0 | 0 | |
| XII. TAXATION | 151 | |||||
| XIII. PROFIT OR LOSS FOR THE PERIOD (148-151) | 152 | 2.675.636 | 2.675.636 | 3.320.002 | 3.320.002 | |
| 1. Profit for the period (149-151) | 153 | 2.675.636 | 2.675.636 | 3.320.002 | 3.320.002 | |
| 2. Loss for the period (151-148) | 154 | 0 | 0 | 0 | 0 |
| ADDITION TO PROFIT AND LOSS ACCOUNT (only for consolidated financial statements) | ||||||
|---|---|---|---|---|---|---|
| XIV. PROFIT OR LOSS FOR THE PERIOD | ||||||
| 1. Attributable to majority owners | 155 | |||||
| 2. Attributable to minority interest | 156 | |||||
| STATEMENT OF OTHER COMPREHENSIVE INCOME (only for IFRS adopters) | ||||||
| I. PROFIT OR LOSS FOR THE PERIOD (=152) | 157 | |||||
| II. OTHER COMPREHENSIVE INCOME/LOSS BEFORE TAXES (159 to 165) | 158 | 0 | 0 | 0 | 0 | |
| 1. Exchange differences from international settlement | 159 | |||||
| 2. Changes in revaluation reserves of long-term tangible and intangible assets | 160 | |||||
| 3. Profit or loss from re-evaluation of financial assets held for sale | 161 | |||||
| 4. Profit or loss from cash flow hedging | 162 | |||||
| 5. Profit or loss from hedging of foreign investments | 163 | |||||
| 6. Share of other comprehensive income/loss from associatied companies | 164 | |||||
| 7. Actuarial gains/losses from defined benefit plans | 165 | |||||
| III. TAXATION OF OTHER COMPREHENSIVE INCOME FOR THE PERIOD | 166 | |||||
| IV. NET OTHER COMPREHENSIVE INCOME FOR THE PERIOD (158 - 166) | 167 | 0 | 0 | 0 | 0 | |
| V. COMPREHENSIVE INCOME OR LOSS FOR THE PERIOD (157+167) | 168 | 0 | 0 | 0 | 0 | |
| ADDITION TO STATEMENT OF OTHER COMPREHENSIVE INCOME (only for consolidated financial statements) | ||||||
| VI. COMPREHENSIVE INCOME OR LOSS FOR THE PERIOD | ||||||
| 1. Attributable to majority owners | 169 | |||||
| 2. Attributable to minority interest | 170 |
Cash flow statement - indirect method period 01/01/2018 to 31/03/2018
| Company: ILIRIJA d.d. BIOGRAD NA MORU | |||
|---|---|---|---|
| Position | AOP | Previous period |
Current period |
| 1 | 2 | 3 | 4 |
| CASH FLOWS FROM OPERATING ACTIVITIES | |||
| 1. Profit before tax | 001 | 2.675.636 | 3.320.002 |
| 2. Depreciation and amortisation | 002 | 2.551.212 | 2.788.869 |
| 3. Increase of current liabilities | 003 | ||
| 4. Decrease of current receivables | 004 | ||
| 5. Decrease of inventories | 005 | 145.036 | |
| 6. Other cash flow increases | 006 | ||
| I. Total increase of cash flow from operating activities | 007 | 5.226.848 | 6.253.907 |
| 1. Decrease of current liabilities | 008 | 9.661.705 | 3.733.813 |
| 2. Increase of current receivables | 009 | 337.537 | 1.317.026 |
| 3. Increase of inventories | 010 | 251.258 | |
| 4. Other cash flow decreases | 011 | ||
| II. Total decrease of cash flow from operating activities | 012 | 10.250.500 | 5.050.839 |
| A1) NET INCREASE OF CASH FLOW FROM OPERATING ACTIVITIES | 013 | 0 | 1.203.068 |
| A2) NET DECREASE OF CASH FLOW FROM OPERATING ACTIVITIES | 014 | 5.023.652 | 0 |
| CASH FLOW FROM INVESTING ACTIVITIES | |||
| 1. Proceeds from sale of non-current assets | 015 | ||
| 2. Proceeds from sale of non-current financial assets | 016 | ||
| 3. Interest received | 017 | ||
| 4. Dividend received | 018 | ||
| 5. Other proceeds from investing activities | 019 | 2.599.175 | 5.278.932 |
| III. Total cash inflows from investing activities | 020 | 2.599.175 | 5.278.932 |
| 1. Purchase of non-current assets | 021 | 3.933.168 | 3.651.158 |
| 2. Purchase of non-current financial assets | 022 | ||
| 3. Other cash outflows from investing activities | 023 | ||
| IV. Total cash outflows from investing activities | 024 | 3.766.832 | 3.651.158 |
| B1) NET INCREASE OF CASH FLOW FROM INVESTING ACTIVITIES | 025 | 0 | 1.627.774 |
| B2) NET DECREASE OF CASH FLOW FROM INVESTING ACTIVITIES | 026 | 1.167.657 | 0 |
| CASH FLOW FROM FINANCING ACTIVITIES | |||
| 1. Proceeds from issue of equity securities and debt securities | 027 | ||
| 2. Proceeds from loans and borrowings | 028 | 8.278.442 | |
| 3. Other proceeds from financing activities | 029 | ||
| V. Total cash inflows from financing activities | 030 | 8.278.442 | 0 |
| 1. Repayment of loans and bonds | 031 | 2.616.170 | 1.657.510 |
| 2. Dividends paid | 032 | ||
| 3. Repayment of finance lease | 033 | 736.644 | 2.464.203 |
| 4. Purchase of treasury shares | 034 | ||
| 5. Other cash outflows from financing activities | 035 | ||
| VI. Total cash outflows from financing activities | 036 | 3.352.814 | 4.121.713 |
| C1) NET INCREASE OF CASH FLOW FROM FINANCING ACTIVITIES | 037 | 4.925.628 | 0 |
| C2) NET DECREASE OF CASH FLOW FROM FINANCING ACTIVITIES | 038 | 0 | 4.121.713 |
| Total increases of cash flows (013-014+025-026+037-038) | 039 | 0 | 0 |
| Total decreases of cash flows (014-013+026-025+038-037) | 040 | 1.265.681 | 1.290.871 |
| Cash and cash equivalents at the beginning of period | 041 | 2.340.622 | 1.510.864 |
| Increase of cash and cash equivalents | 042 | ||
| Decrease of cash and cash equivalents | 043 | ||
| Cash and cash equivalents at the end of period | 044 | 1.074.941 | 219.993 |
| STATEMENT OF CHANGES IN EQUITY | |||
|---|---|---|---|
| period 31.3.2018 1.1.2018 to |
|||
| Position | AOP | Previous year |
Current year |
| 1 | 2 | 3 | 4 |
| 1. Subscribed share capital | 001 | 174.977.880 | 229.146.480 |
| 2. Capital reserves | 002 | 26.723.874 | 2.723.874 |
| 3. Reserves from profit | 003 | 23.435.964 | 22.758.389 |
| 4. Retained earnings or loss carried forward | 004 | 50.546.190 | 41.326.486 |
| 5. Net profit or loss for the period | 005 | 2.675.636 | 3.320.002 |
| 6. Revaluation of tangible assets | 006 | ||
| 7. Revaluation of intangible assets | 007 | ||
| 8. Revaluation of available for sale assets | 008 | ||
| 9. Other revaluation | 009 | ||
| 10. Total equity and reserves (AOP 001 to 009) | 010 | 278.359.544 | 299.275.231 |
| 11. Foreign exchenge differences from foreign investments | 011 | ||
| 12. Current and deferred taxes | 012 | ||
| 13. Cash flow hedge | 013 | ||
| 14. Change of accounting policies | 014 | ||
| 15. Correction of significant mistakes pf prior period | 015 | ||
| 16. Other changes | 016 | ||
| 17.Total increase or decrease of equity (AOP 011 to 016) | 017 | 59.348.843 | 20.915.687 |
| 17 a. Attributable to majority owners | 018 | ||
| 17 b. Attributable to minority interest | 019 |
More from Ilirija d.d.
Interim / Quarterly Report
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Report Publication Announcement
2026
Apr 29
Report Publication Announcement
2026
Apr 29
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 22
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 22
AGM Information
2026
Feb 26
Proxy Solicitation & Information Statement
2026
Feb 26